1
|
Afolabi OA, Salaudeen AG, Ologe FE,
Nwabuisi C and Nwawolo CC: Pattern of bacterial isolates in the
middle ear discharge of patients with chronic suppurative otitis
media in a tertiary hospital in North central Nigeria. Afr Health
Sci. 12:362–367. 2012.PubMed/NCBI
|
2
|
Paparella MM, Schachern PA, Yoon TH,
Abdelhammid MM, Sahni R and da Costa SS: Otopathologic correlates
of the continuum of otitis media. Ann Otol Rhinol Laryngol Suppl.
148:17–22. 1990.PubMed/NCBI
|
3
|
da Costa SS, Paparella MM, Schachern PA,
Yoon TH and Kimberley BP: Temporal bone histopathology in
chronically infected ears with intact and perforated tympanic
membranes. Laryngoscope. 102:1229–1236. 1992. View Article : Google Scholar : PubMed/NCBI
|
4
|
Kaya E, Dag I, Incesulu A, Gurbuz MK, Acar
M and Birdane L: Investigation of the presence of biofilms in
chronic suppurative otitis media, nonsuppurative otitis media, and
chronic otitis media with cholesteatoma by scanning electron
microscopy. ScientificWorldJournal. 2013:6387152013. View Article : Google Scholar : PubMed/NCBI
|
5
|
Forséni M, Hansson GK, Bagger-Sjöbäck D
and Hultcrantz M: Infiltration of immunocompetenT cells in the
middle ear during acute otitis media: A temporal study. Am J Otol.
20:152–157. 1999.PubMed/NCBI
|
6
|
Kähönen K, Palva T, Bergroth V, Konttinen
YT and Reitamo S: Immunohistochemical identification of
inflammatory cells in secretory and chronic otitis media and
cholesteatoma using monoclonal antibodies. Acta Otolaryngol.
97:431–436. 1984. View Article : Google Scholar : PubMed/NCBI
|
7
|
Yamanaka T, Bernstein JB, Cumella J,
Parker C and Ogra PL: Immunologic aspects of otitis media with
effusion: Characteristics of lymphocyte and macrophage reactivity.
J Infect Dis. 145:804–810. 1982. View Article : Google Scholar : PubMed/NCBI
|
8
|
Baumann R, Yousefi S, Simon D, Russmann S,
Mueller C and Simon HU: Functional expression of CD134 by
neutrophils. Eur J Immunol. 34:2268–2275. 2004. View Article : Google Scholar : PubMed/NCBI
|
9
|
Gramaglia I, Weinberg AD, Lemon M and
Croft M: Ox-40 ligand: A potent costimulatory molecule for
sustaining primary CD4 T cell responses. J Immunol. 161:6510–6517.
1998.PubMed/NCBI
|
10
|
Żelazowska-Rutkowska B, Wysocka J,
Ratomski K, Kasprzycka E and Skotnicka B: Increased percentage of T
cells with the expression of CD127 and CD132 in hypertrophic
adenoid in children with otitis media with effusion. Eur Arch
Otorhinolaryngol. 269:1821–1825. 2012. View Article : Google Scholar : PubMed/NCBI
|
11
|
Sharma SK, Casey JR and Pichichero ME:
Reduced memory CD4+ T-cell generation in the circulation
of young children may contribute to the otitis-prone condition. J
Infect Dis. 204:645–653. 2011. View Article : Google Scholar : PubMed/NCBI
|
12
|
Sakaguchi S, Miyara M, Costantino CM and
Hafler DA: FOXP3+ regulatory T cells in the human immune
system. Nat Rev Immunol. 10:490–500. 2010. View Article : Google Scholar : PubMed/NCBI
|
13
|
Redmond WL, Ruby CE and Weinberg AD: The
role of OX40-mediated co-stimulation in T-cell activation and
survival. Crit Rev Immunol. 29:187–201. 2009. View Article : Google Scholar : PubMed/NCBI
|
14
|
Devaud C, Darcy PK and Kershaw MH: Foxp3
expression in T regulatory cells and other cell lineages. Cancer
Immunol Immunother. 63:869–876. 2014. View Article : Google Scholar : PubMed/NCBI
|
15
|
Germanidis G, Argentou N, Hytiroglou P,
Vassiliadis T, Patsiaoura K, Germenis AE and Speletas M: Liver
FOXP3 and PD1/PDL1 expression is down-regulated in chronic HBV
hepatitis on maintained remission related to the degree of
inflammation. Front Immunol. 4:2072013. View Article : Google Scholar : PubMed/NCBI
|
16
|
Coria-Ramírez É, Vargas-Camaño ME,
Guido-Bayardo RL, García-Castillo G, Zepeda-García C, Mèndez-Medina
J and Castrejón-Vázquez MI: Levels of CD4+ and
FOXP3+ lymphocytes in patients with allergic rhinitis.
Rev Alerg Mex. 60:5–10. 2013.(In Spanish). PubMed/NCBI
|
17
|
Wang DN, Li J, Zhao SQ, Wang Y and Yang L:
Role of FOXP3 CD4 CD25 T cells in otitis media with effusion.
Chinese Archives of Otolaryngology-Head and Neck Surgery.
20:126–128. 2013.
|
18
|
Mallett S, Fossum S and Barclay AN:
Characterization of the MRC OX40 antigen of activated CD4 positive
T lymphocytes -a molecule related to nerve growth factor receptor.
EMBO J. 9:1063–1068. 1990.PubMed/NCBI
|
19
|
Ewen CL, Kane KP and Bleackley RC: A
quarter century of granzymes. Cell Death Differ. 19:28–35. 2012.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Chowdhury D and Lieberman J: Death by a
thousand cuts: Granzyme pathways of programmed cell death. Annu Rev
Immunol. 26:389–420. 2008. View Article : Google Scholar : PubMed/NCBI
|